November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreOctober 13, 2025
According to forecasts, the Europe cell and gene therapy market will grow from USD 2.74 billion in 2024 to USD 48.96 billion by 2034, with an expected CAGR of 23.90%. The Europe cell and gene therapy market is growing due to the growing incidence of genetic diseases and enhanced regulatory frameworks....
October 13, 2025
According to forecasts, the North America cell and gene therapy market will grow from USD 9.19 billion in 2024 to USD 79.01 billion by 2034, with an expected CAGR of 24.01%. The North America cell and gene therapy market is growing due to the rising demand for highly specific therapeutics for genetic disorders....
October 13, 2025
The cell and gene therapy infrastructure market is growing due to advances in gene editing technology and the increasing prevalence of genetic and chronic diseases. North America is dominant in the market due to the robust public and private spending....
October 10, 2025
According to forecasts, the global myasthenia gravis treatment market will grow from USD 1.55 billion in 2024 to USD 3.29 billion by 2034, with an expected CAGR of 7.84%. The myasthenia gravis treatment market is growing due to the rising prevalence of myasthenia gravis (MG), the growing aging population, and enhanced diagnostic abilities. North Am...
October 09, 2025
Market insights predict, the Latin America cell and gene therapy industry is expected to grow from USD 1.15 billion in 2024 to USD 10.19 billion by 2034, driven by a CAGR of 24.40%. The rising prevalence of chronic and genetic diseases is expected to drive the growth of the market....
October 08, 2025
Projections indicate that, the global generative AI in drug discovery market will increase from USD 250 million in 2024 to USD 2847.43 million by 2034, experiencing a CAGR of 27.42% over the next 10 years. The generative AI in drug discovery market is growing rapidly due to technological advancements and rising government initiatives to develop nov...
October 08, 2025
Projections indicate that, APAC cell and gene therapy industry is projected to rise from USD 4.59 billion in 2024 to USD 39.62 billion by 2034, reflecting a CAGR of 24.04% over the next decade. A surge in wider demand for advanced therapies due to rising severe concerns, like cancers, rare disorders, is supporting the overall market growth. China d...
October 08, 2025
Projections indicate that, the Middle East and Africa cell and gene therapy market will increase from USD 1.15 billion in 2024 to USD 9.75 billion by 2034, experiencing a CAGR of 23.85% over the next 10 years. The burgeoning biotechnology sector and the growing demand for personalized medicines drive the market....
October 07, 2025
Market insights predict the North America behavioral health industry will increase from USD 109.21 billion in 2024 to USD 193.03 billion by 2034, achieving a CAGR of 5.86%. The rising incidence of substance use and mental disorders, increased health awareness, and improved patient care fuel the need for behavioral health solutions. North America do...
October 06, 2025
According to forecasts, the global regenerative medicine market will grow from USD 20.09 billion in 2024 to USD 139.70 billion by 2034, with an expected CAGR of 21.4%. North America leads the regenerative medicine market with a 49.21% share. The wound care segment is the fastest-growing, expected to expand at a 17.3% CAGR from 2023 to 2032. Es...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com